Array
(
[0] => stdClass Object
(
[id] => 1376
[id_crawler] =>
[category_product] => NULL
[thumbnail] => 600x400-web-gentis-15-nam.jpg
[album] =>
[url_video] =>
[is_status] => 1
[is_featured] => 0
[is_form] => 0
[displayed_time] => 2025-10-26
[program] => 0
[number] => 1
[viewed] => 0
[type] =>
[type_career] =>
[level] =>
[address] =>
[address_career] =>
[expiration_time] => 0000-00-00
[created_time] => 2025-10-28 08:55:32
[updated_time] => 2025-10-29 10:00:15
[files] =>
[salary] =>
[time] =>
[created_by] => 63
[is_table_content] => 1
[language_code] => en
[slug] => GENTIS-15-years-sowing-aspirations-reaping-trust
[title] => GENTIS 15 Years – sowing aspirations, reaping trust
[description] => On October 26, 2010, a small milestone was marked in the field of biomedical science in Vietnam: GENTIS – the first genetic testing center in Hanoi – was founded. Few knew that from this modest beginning, a 15-year journey of perseverance and dedication to the mission “Enhancing the Physical and Intellectual Health of Vietnamese People” would unfold, built on trust, knowledge, and resilience to overcome every challenge.
[content] => From first steps to remarkable achievements in genetics
Starting in Hanoi with the aspiration to “pioneer the field of genetics,” GENTIS was among the first institutions in Vietnam to introduce access to genetic science – a technology largely unfamiliar to most people at that time. Driven by strong faith in the future, within just three years, GENTIS opened a branch in Ho Chi Minh City, marking the first step in bringing the world’s most advanced genetic technology closer to Vietnamese people.
In 2015, GENTIS became the first DNA laboratory in Vietnam to achieve ISO 9001:2015 certification, with its testing systems built according to the recommendations of the U.S. FBI. This was not only an achievement but a strong affirmation of GENTIS’s commitment to quality and international standards as the foundation for its development.
Continuing its growth, in 2017 GENTIS expanded into oncology and infectious disease testing. By 2018, GENTIS reached the international stage as an official partner of Illumina (USA), the world leader in gene sequencing.
From 2019 to 2020, GENTIS focused on providing genetic analysis solutions to support reproductive health and comprehensive healthcare, consistently placing people at the center of every development strategy.
In 2021, the Covid-19 pandemic posed a significant test for the healthcare sector, and GENTIS stepped up. The company became one of the few private healthcare facilities certified for SARS-CoV-2 testing, collaborating with Hanoi CDC on large-scale community testing campaigns. GENTIS staff worked tirelessly on the front lines, collecting samples and running tests, contributing to the protection of millions of people across the country.
In 2022, GENTIS officially became a member of Eurofins – the world’s leading medical group – marking a historic turning point and elevating GENTIS to an international brand. This was not just a legal merger but a complete transformation in processes, personnel, mindset, and technology.
Building on this success, in 2024 Eurofins – GENTIS inaugurated a new, modern 2,000 m² headquarters in central Hanoi, a significant step in both scale and readiness to meet the growing and increasingly complex testing needs of domestic and international clients.
GENTIS hosts CAP expert delegation to evaluate Hanoi laboratory
After more than a year of relentless effort, hundreds of strict criteria, and thousands of hours of quality inspections, in June 2025, Eurofins – GENTIS became the pioneering unit in Vietnam to achieve CAP certification for two core genetic tests: PGT and NIPT. For the first time, a genetic testing facility in Vietnam was recognized internationally at the highest level for quality and expertise in the two most advanced techniques in reproductive support and prenatal screening. This achievement was not only GENTIS’s success but also a step forward for Vietnam’s biomedical industry on the global map.
Raising the standards of Vietnamese genetic medicine
GENTIS has contributed not only to its own growth but also to the advancement of Vietnam’s biomedical sector. Deep genetic tests, which previously had to be sent abroad at high costs, can now be performed domestically with equivalent quality. As shared by Assoc. Prof. Dr. Nguyen Dinh Tao, Chairman of the Hanoi Association for Reproductive Support: “GENTIS participates in conferences, workshops, and scientific activities both in-person and online. With its professional expertise, personnel, and advanced medical equipment and technology, GENTIS has helped introduce modern genetic testing technologies in Vietnam, particularly in reproductive support.”

Prof. Tao added: “Previously, many genetic tests for reproductive support had to be done overseas at high costs. Now, units like GENTIS have applied advanced technology and equipment locally, playing a crucial role in developing Vietnam’s reproductive support sector and improving success rates. As a result, infertile couples, including overseas Vietnamese, can now return to Vietnam for reproductive support services.”
Moreover, GENTIS actively collaborates with hospitals, universities, and international organizations to bring applied scientific value closer to the Vietnamese medical community.
Linking business growth with social responsibility
Beyond professional development, GENTIS pursues community initiatives, such as:

People – the heart of every achievement
Over 15 years, equipment and technology may evolve, but the soul of GENTIS lies in its people. From resident doctors, R&D specialists, project managers, sample collectors, lab technicians, business and customer care staff, to HR, accounting, marketing, legal, ISO, and procurement teams – all are professionally trained, continuously updating their knowledge and skills.
GENTIS leadership recognizes that quality is the company’s core value, and thus has built a dedicated, loyal, and constantly improving workforce.

To nurture this internal “family,” GENTIS organizes annual events such as Year-End Party, Lunar New Year outings, annual trips, comprehensive health checkups, company birthdays, and more, fostering unity and a strong, cohesive team.
Future direction: Continuous innovation – continuous quality improvement
Regarding future development, Mr. Do Manh Ha stated that Eurofins – GENTIS has clearly defined goals:
15 years – leading and growing
Fifteen years may not be a long journey, but it has firmly placed GENTIS on Vietnam’s genetic medicine map, leaving a lasting impression on customers, partners, and the community. GENTIS is proud to have accompanied families in tracing their roots, infertile couples on their journey to parenthood, and protecting the health of future generations.
GENTIS will continue to advance with Vietnamese heart, Vietnamese intellect, and international standards, committed to constantly improving services to meet global benchmarks in genetic and genomic testing.
[content_more] => [meta_title] => GENTIS 15 Years – sowing aspirations, reaping trust [meta_description] => On October 26, 2010, a small milestone was marked in the field of biomedical science in Vietnam: GENTIS – the first genetic testing center in Hanoi – was founded. [meta_keyword] => [thumbnail_alt] => [post_id] => 1376 [category_id] => 14 ) [1] => stdClass Object ( [id] => 1375 [id_crawler] => [category_product] => NULL [thumbnail] => my205757.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2025-10-26 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2025-10-28 08:46:10 [updated_time] => 2025-10-29 09:41:21 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => GENTIS-15-years-of-creating-value-for-public-health [title] => GENTIS – 15 years of creating value for public health [description] => On the evening of October 25, 2025, in the beautiful coastal city of Ha Long, GENTIS Genetic Analysis Services Joint Stock Company (GENTIS) solemnly held its 15th Anniversary Celebration (October 26, 2010 – October 26, 2025) in a warm, heartfelt, and highly emotional atmosphere. [content] =>The event served as an opportunity for all employees, customers, and partners to reflect on the proud journey so far while fueling motivation to move forward toward the future with unwavering belief and ambition.
A Milestone journey – 15 years of steady progress
Since its founding in 2010, GENTIS has continuously grown and established a leading position in the field of genetic analysis in Vietnam. With a long-term vision, sustainable development strategy, and a high-quality workforce, GENTIS has become a pioneering symbol in applying genetic technology for healthcare.

Over the past 15 years, the journey has been full of effort and challenges, yet marked by remarkable achievements:
GENTIS has played an important role in modernizing Vietnamese medicine through the application of advanced genetic testing solutions for diagnosis, treatment, and disease prevention.
A warm, emotional, and memorable celebration
Held in one of the country’s most famous tourist destinations – Ha Long, the anniversary celebration was not only a milestone event but also an occasion for everyone to share, express gratitude, and connect. The ceremony began with a commemorative photo session of the leadership board, employees, and guests. The space was vibrant with colors, dazzling lights, and cheerful laughter, creating a cozy start to a grand event.

Following that, the audience enjoyed lively performances organized and performed by GENTIS members themselves. Heroic songs and graceful dances not only showcased artistic talent but also reflected the spirit of unity, creativity, and enthusiasm – hallmarks of GENTIS culture.



Highlights of the event
One of the most touching moments of the ceremony was the speech by Mr. Đo Manh Ha – CEO of GENTIS. He recounted the company’s 15-year journey of relentless effort and expressed heartfelt gratitude to all employees, partners, and customers – those who have accompanied, continue to accompany, and will accompany GENTIS in its mission to serve public health.



Mr. Đo Manh Ha also reaffirmed the company’s strategic vision for the next phase, in which GENTIS will continue to:

One of the most impressive moments was the recognition of employees with 5, 10, and 15 years of service. These are the people who have devoted themselves to building GENTIS into the strong company it is today. Each name called, each bouquet presented, each warm embrace brought happiness, pride, and a sense that their contributions are always valued.
Following the recognition ceremony was the most meaningful moment: the leadership and management team raised their glasses and cut the birthday cake, officially marking GENTIS’s 15th anniversary. The cake, designed with the GENTIS logo in hopeful green and pure white, symbolized a firm belief in the company’s bright future.
This moment was not only a summary of a remarkable journey but also the starting point for the paths ahead, where GENTIS will continue to grow, innovate, and serve the health of millions of Vietnamese people.
Looking ahead
The 15th-anniversary celebration was not only a time to reflect on the past but also a strong affirmation that GENTIS will not stop here.
With a strategic vision, modern technology foundation, and talented workforce, GENTIS continues to develop a comprehensive genetic ecosystem with outstanding services such as family testing, non-invasive prenatal testing (NIPT), pre-marital and prenatal genetic counseling, and other genetic tests.
GENTIS’s growth is not only a corporate achievement but also a source of pride for Vietnamese medicine in its integration with global trends in personalized healthcare.
15 years – A journey of trust, value, and leadership
For GENTIS, this is just the beginning of an even brighter journey ahead. Once again, congratulations to GENTIS on its 15th anniversary! Wishing the company continued growth and to remain a trusted companion for millions of Vietnamese families in caring for and protecting health through genetic science.
[content_more] => [meta_title] => GENTIS – 15 years of creating value for public health [meta_description] => On the evening of October 25, 2025, in the beautiful coastal city of Ha Long, GENTIS Genetic Analysis Services Joint Stock Company (GENTIS) solemnly held its 15th Anniversary Celebration (October 26, 2010 – October 26, 2025) in a warm, heartfelt, and high [meta_keyword] => [thumbnail_alt] => [post_id] => 1375 [category_id] => 14 ) [2] => stdClass Object ( [id] => 1374 [id_crawler] => [category_product] => NULL [thumbnail] => 565146852_1222653929882222_4756649354324039800_n_(1).jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 1 [displayed_time] => 2025-10-28 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2025-10-28 08:27:20 [updated_time] => 2025-10-28 10:10:27 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => GENTIS-honored-to-welcome-CAP-expert-delegation-at-headquarters-Hanoi [title] => GENTIS honored to welcome CAP expert delegation at headquarters - Hanoi [description] => On October 17, 2025, GENTIS had the honor of welcoming a delegation of senior experts from the College of American Pathologists (CAP) – the world’s leading organization in clinical laboratory accreditation – to visit and work at its headquarters in Hanoi. [content] =>This visit marks a significant milestone, underscoring the strong and enduring partnership between GENTIS and CAP in maintaining and advancing international quality standards for laboratory testing in Vietnam. It also provided an opportunity for both parties to engage in in-depth discussions on sustainable development strategies and future cooperation directions, contributing to the growth of Vietnam’s genetic testing industry to regional and global levels.
The CAP delegation included senior leaders with extensive experience in laboratory science and international market development. Among them were Ms. Xiaocong (Angra) Wang, Regional Leader for Southeast Asia, South Asia, and Oceania; Ms. Elizabeth Tudor, Senior Leader in Global Support and Development; Mr. Sean Harrington, Director of International Market Development; and Mr. Brian Nowlin, Vice President of International Market Development at CAP. The participation of these distinguished experts brought valuable insights, strategic perspectives, and collaboration opportunities for advancing testing standards in Vietnam.

During the working session, the CAP delegation and GENTIS leadership, along with its technical team, exchanged knowledge and international experience in laboratory quality management. They also shared strategic perspectives on developing efficient operational models aimed at transparency and standardization in accordance with CAP standards. The delegation directly visited the PGT and NIPT laboratories, both of which achieved CAP accreditation in June 2025—an important milestone affirming GENTIS’s commitment to quality and credibility.
The College of American Pathologists (CAP) is one of the most prestigious organizations in the world for medical laboratory accreditation and inspection, recognized in over 100 countries. Achieving CAP accreditation means that a laboratory meets the most stringent requirements for operational processes, personnel competence, and test result accuracy. Therefore, GENTIS’s attainment of this certification is not only a source of pride but also clear evidence of its continuous efforts to ensure world-class service quality.
During the visit, the CAP delegation highly commended GENTIS for its investment in modern equipment, strict adherence to quality management procedures, and development of a highly qualified workforce. GENTIS’s achievements in implementing CAP standards reaffirm its professional expertise and pioneering position in the field of genetic testing.
GENTIS is committed to providing laboratory testing services that are accurate, safe, and transparent. Its continuous efforts to maintain, strengthen, and expand international standards such as CAP demonstrate GENTIS’s strong commitment to quality and sustainable development.

The visit and working session with the CAP delegation not only recognized GENTIS’s accomplishments but also opened new avenues for potential collaboration in the future. With a solid foundation of expertise, technology, and human resources, GENTIS continues to affirm its leading position in genetic testing in Vietnam and contributes to the advancement of modern medicine in the region.
[content_more] => [meta_title] => GENTIS honored to welcome CAP expert delegation at headquarters - Hanoi [meta_description] => On October 17, 2025, GENTIS had the honor of welcoming a delegation of senior experts from the College of American Pathologists (CAP) – the world’s leading organization in clinical laboratory accreditation – to visit and work at its headquarters in Hanoi. [meta_keyword] => GENTIS [thumbnail_alt] => [post_id] => 1374 [category_id] => 14 ) [3] => stdClass Object ( [id] => 1373 [id_crawler] => [category_product] => NULL [thumbnail] => 565773600_1223544959793119_2949476054075220034_n.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 1 [displayed_time] => 2025-10-27 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2025-10-27 16:45:28 [updated_time] => 2025-10-28 10:38:29 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => GENTIS-welcomes-CAMMED-Medical-Laboratory-for-a-visit-and-collaboration-expanding-international-cooporation-for-public-health [title] => GENTIS welcomes CAMMED Medical Laboratory for a visit and collaboration – expanding international cooperation for public health [description] => On October 18, 2025, at its headquarters in Hanoi, GENTIS Genetic Analysis Services Joint Stock Company proudly welcomed a delegation from CAMMED Medical Laboratory (Cambodia) for a visit and collaborative discussions. The visit marked an important milestone in GENTIS’s international cooperation journey, aiming to bring advanced genetic testing technologies closer to communities across Southeast Asia. [content] =>The CAMMED delegation included members of the Board of Directors, laboratory management, and the business department, led by Ms. Koem Sivfin – Business Director. On the GENTIS side, Mr. Nguyen Manh Ha – CEO, Mr. Pham Dinh Minh – R&D Director, and Ms. Hang Le – International Cooperation Coordinator, attended the meeting.

During the session, GENTIS representatives provided an overview of the company’s operations, professional capabilities, internationally accredited laboratory systems, and advanced genetic testing technologies such as PGT and NIPT.
The CAMMED delegation expressed deep admiration for GENTIS’s modern facilities, rigorous quality control processes, and highly experienced team of experts. Both sides discussed trends in the regional genetic testing industry, shared operational experiences, and explored potential cooperation in training, technology transfer, and applied research.
One key topic of discussion was the plan to expand NIPT services in Cambodia. Drawing from successful implementation in Vietnam, GENTIS shared operational models, professional workflows, and quality assurance standards, enabling CAMMED to develop effective and sustainable prenatal screening services in Cambodia.
Additionally, GENTIS introduced its PGT service – preimplantation genetic testing, an advanced reproductive solution that helps select healthy embryos before in vitro fertilization (IVF). This service is expected to be implemented soon by CAMMED, providing opportunities for many families facing infertility.
The CAMMED delegation also toured GENTIS’s state-of-the-art laboratories and met partner clinics in Hanoi, learning about the connection model between GENTIS and domestic healthcare facilities – an essential foundation for applying this model in the Cambodian market.

The meeting took place in a friendly, professional, and open atmosphere. Both sides affirmed that cooperation between GENTIS and CAMMED goes beyond business interests, reflecting a shared commitment to providing accurate, safe, and humane genetic testing solutions for the benefit of public health in Southeast Asia.
Ms. Koem Sivfin of CAMMED expressed sincere gratitude for GENTIS’s warm reception and expressed confidence that both sides would soon implement multiple concrete collaborative projects.
The visit and working session of CAMMED Medical Laboratory affirmed GENTIS’s prestige, expertise, and influence in the field of genetic testing in Vietnam and the region. It provides an important foundation for GENTIS to continue expanding international cooperation and, together with regional partners, to spread the value of advanced medical science and technology, aiming for comprehensive and sustainable public health care.
[content_more] => [meta_title] => GENTIS welcomes CAMMED Medical Laboratory for a visit and collaboration – expanding international co [meta_description] => On October 18, 2025, at its headquarters in Hanoi, GENTIS Genetic Analysis Services Joint Stock Company proudly welcomed a delegation from CAMMED Medical Laboratory (Cambodia) for a visit and collaborative discussions. [meta_keyword] => GENTIS [thumbnail_alt] => [post_id] => 1373 [category_id] => 14 ) [4] => stdClass Object ( [id] => 1372 [id_crawler] => [category_product] => NULL [thumbnail] => 565102005_1221798849967730_2421886531515618477_n.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2025-10-22 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2025-10-22 13:36:34 [updated_time] => 2025-10-28 10:24:37 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => Screening-and-dianostic-test-panel-for-male-infertility-Experience-from-Eurofins-GENTIS-labolatory [title] => Screening and diagnostic test panel for male infertility: Experience from Eurofins - GENTIS laboratory [description] => Male infertility is a sensitive topic that is sometimes overlooked during infertility consultations. However, in reality, it accounts for nearly 50% of infertility cases among couples. While women are often evaluated early, many men are not diagnosed in time, leading to delayed treatment or even the selection of inappropriate assisted reproductive methods. [content] =>In response to this reality, Eurofins - GENTIS has developed a comprehensive testing panel aimed at accurately screening and diagnosing the causes of male infertility. This panel not only helps doctors identify the root causes but also allows for individualized treatment plans, optimizing the chances of conception for couples.
Medical research shows that male infertility can arise from multiple causes: about 70% result from testicular defects, 15% are related to endocrine disorders, 5% involve sperm motility issues, and 10% remain unexplained. Notably, genetic factors are implicated in approximately 15% of male infertility cases. These factors may include chromosomal abnormalities, gene mutations, or epigenetic disorders, which cannot be detected using standard tests. Early detection of these genetic factors is crucial not only for accurately assessing spermatogenic potential but also for preventing the transmission of genetic disorders to future generations through controlled assisted reproductive methods such as IVF combined with PGT-M.
Dr. Vu Thu Huong (GENTIS) presented on genetic causes of male infertility at the VSSM 2025 Conference
Therefore, the process of evaluating male infertility follows a standardized protocol in line with recommendations from the European Association of Urology (EAU, 2025), the American Society for Reproductive Medicine (ASRM), and expert consensus. First, all men suspected of infertility undergo a thorough medical history review and clinical examination to evaluate relevant parameters.
The goal of the initial assessment is to identify cases that can be treated or couples with male-factor infertility who may benefit from assisted reproductive interventions. Depending on the results, further investigations may be conducted, such as testicular ultrasound to detect conditions like hydrocele or varicocele—common but treatable causes if detected early. Physicians may also order endocrine and extended tests, particularly genetic tests, to identify the underlying cause of infertility.
Semen analysis is the first and fundamental test for evaluating sperm quality. It measures sperm concentration, motility, and morphology. If abnormalities are found, the test is typically repeated after 2–3 weeks to rule out temporary factors such as stress, acute illness, or environmental influences. Additionally, endocrine evaluation through FSH, LH, and testosterone levels helps differentiate primary versus secondary hypogonadism, especially in cases with very low sperm counts (<5 million/mL).
Karyotype testing is a key genetic test performed at Eurofins - GENTIS. It is indicated for patients with azoospermia or severe oligozoospermia (sperm count <5 million/mL) to detect numerical or structural chromosomal abnormalities, such as Klinefelter syndrome (47,XXY) or chromosomal deletions and translocations. This allows physicians to provide prognosis regarding spermatogenic potential and guide appropriate treatment.
Dr. Huong shared various screening and diagnostic tests for male infertility
Another common genetic cause of male infertility is microdeletions in the AZF region of the Y chromosome, which is the second most frequent genetic factor after chromosomal abnormalities. AZFa, AZFb, and AZFc regions contain genes essential for spermatogenesis, and deletions in these areas can directly cause infertility. Testing is indicated for azoospermic men or those with sperm counts below 5 million/mL, and is mandatory for counts below 1 million/mL. Identifying deletions in AZFa or AZFb is crucial because affected patients typically lack spermatogenic potential, preventing unnecessary interventions, while AZFc deletions may still allow for sperm retrieval and assisted reproduction. This test also plays a role in genetic counseling, as Y chromosome deletions in the father can be inherited by sons via ICSI.
Another cause of obstructive male infertility is congenital absence of the vas deferens (CBAVD), commonly associated with CFTR gene mutations causing cystic fibrosis. Men with low semen volume (<1 mL), acidic semen (pH <7.0), and absent sperm, along with relevant clinical history, are tested for CFTR mutations. At GENTIS, this test uses PCR combined with Sanger sequencing to detect 22 common CFTR mutations, including variants like Val470Met and Arg117His, as well as IVS8 polymorphisms. Results allow physicians to identify CBAVD-related infertility and plan treatments such as vas deferens reconstruction, testicular sperm extraction, or IVF/ICSI, while providing genetic counseling to prevent cystic fibrosis in offspring.
Beyond basic genetic tests, sperm DNA fragmentation (SDF) testing is an important tool in diagnosing male infertility, particularly in unexplained infertility, recurrent miscarriage, or repeated IVF/ICSI failure. At GENTIS, SDF is performed using the SCSA method, which employs specialized fluorescent dyes and flow cytometry to assess sperm DNA damage. Based on SDF results, physicians can recommend lifestyle modifications (e.g., quitting smoking, weight loss, reducing environmental toxin exposure, antioxidant supplementation) or interventions such as varicocele repair or advanced sperm selection techniques like PICSI or MACS to improve treatment outcomes.
Dr. Huong discussed the benefits of genetic testing in male infertility screening and diagnosis
At the 2025 National VSSM Scientific Conference, MSc. Dr. Vu Thu Huong (R&D Specialist at GENTIS) noted that in 30–40% of cases, even after all standard tests, the cause of infertility remains unknown. Next-generation sequencing (NGS) offers a breakthrough by analyzing large panels of genes related to spermatogenesis, identifying rare or novel mutations. Targeted gene panels or whole exome sequencing (WES) can determine molecular-level causes. However, incidental findings or variants of uncertain significance (VUS) may complicate counseling and treatment decisions. GENTIS has a team of genetic experts capable of multidisciplinary consultation and international database review to provide personalized guidance.
Dr. Huong emphasized that not every patient requires genetic testing; it should be performed only with clear clinical indications. Selecting the appropriate test prevents unnecessary interventions, accurately identifies the cause of infertility, enables individualized treatment, informs the choice of assisted reproduction methods, guides PGT-M if needed, and most importantly, reduces risk for future generations.
With over 15 years of experience in genetic testing, Eurofins - GENTIS is a pioneer in Vietnam in applying genetic diagnostics to male infertility. Beyond being a laboratory, GENTIS collaborates with doctors, fertility centers, and patients to make precise, individualized treatment decisions, ultimately helping couples achieve their dream of parenthood safely and sustainably.
[content_more] => [meta_title] => Screening and diagnostic test panel for male infertility: Experience from Eurofins - GENTIS laborato [meta_description] => Male infertility is a sensitive topic that is sometimes overlooked during infertility consultations. [meta_keyword] => GENTIS,PGT [thumbnail_alt] => [post_id] => 1372 [category_id] => 14 ) [5] => stdClass Object ( [id] => 1371 [id_crawler] => [category_product] => NULL [thumbnail] => 3721ee01d0e65db804f7.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2025-10-22 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2025-10-22 13:23:10 [updated_time] => 2025-10-28 10:06:32 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => Hanoi-mother-overwhelmed-with-emotion-after-finding-her-daugter-in-France-thanks-to-Dantri-newspaper [title] => Hanoi Mother Overwhelmed with Emotion After Finding Her Daughter in France Thanks to Dan Tri Newspaper [description] => Thanks to the active involvement of Dan Tri newspaper, Mrs. La Thi Hong has found her daughter La Thi Hong Hanh (known by her French name, Léa) — who was adopted to France 31 years ago. [content] =>At 5 p.m., while diligently sweeping the street in Ha Dong Ward, Mrs. La Thi Hong (an environmental worker living in Hanoi) received a special call from GENTIS informing her that the DNA test results confirmed a mother-child biological relationship between her and the girl Léa living in France.
Tears streamed down the weathered face of a woman who has lived more than half her life burdened by the guilt of abandoning her newborn daughter. Looking at the numbers on the DNA test report, Mrs. Hong could hardly believe it was true.

Since learning about her daughter, Mrs. Hong had been anxious and sleepless, waiting for the day of the DNA test. “After 31 years, I feel relieved knowing that my abandoned daughter is living a happy life in Europe. I sincerely thank Dan Tri newspaper for bringing me the greatest happiness in my life,” Mrs. Hong shared.
Previously, Léa had sent samples of her hair and fingernails to Vietnam for the DNA test. On the morning of October 17, Mrs. Hong went to the GENTIS testing center in Hanoi to have her blood sample taken to verify the biological relationship with the girl whose information matched her story.
The Ending After 31 Years of Torment
In June, Mrs. Hong contacted Dan Tri to ask for help finding her daughter, who had been adopted to France.
In 1992, Mrs. Hong fell in love with a young man from a neighboring village. After a year of dating, she found herself unexpectedly pregnant. However, the young man coldly denied responsibility.
After many sleepless nights filled with tears, she decided to keep the baby and raise the child alone, despite the village gossip. On January 2, 1994, the baby girl was born and named La Thi Hong Hanh. Being a single mother with difficult circumstances, Mrs. Hong left her daughter at an orphanage in Soc Sơn.
A few months later, filled with regret, she returned to find her child but was told by the caretaker that the baby had been adopted by a family in France. Mrs. Hong sadly returned to her hometown, carrying the burden of guilt for more than 30 years.
“Back then, having a child out of wedlock was a serious issue in the village. If people were more open-minded like now, I would never have abandoned my daughter,” she said, choking with emotion.
After the article “The tragic life of a Hanoi mother, 31 years searching for her abandoned daughter” was published, Dan Tri reporters contacted several organizations in France to search for the girl La Thi Hong Hanh.
Thanks to their active efforts, within two weeks, Dan Tri found a young woman named Léa living in Montreuil — about 10 km from Paris — whose information matched the story Mrs. Hong described. “Looking at her photo, I noticed she has many facial features similar to mine. In the following days, I was anxious and restless, hoping the DNA test results would match,” she said.
Mrs. Hong shared that she did not expect the search to proceed so quickly. A few years ago, she had thought about finding her daughter but didn’t know where to start.
For many years, only her family and close friends knew she had given birth to a daughter before marrying her current husband. When the story was widely shared, most people sympathized with her. However, some neighbors expressed doubt about her conscience, which made her feel hurt.
Although Léa’s birth date and full name on the documents perfectly matched the story from 31 years ago, Mrs. Hong did not want to expect too much, having hoped before but ended up disappointed.
Mrs. Hong had her blood sample taken for DNA testing at the center.
Two years ago, a girl from France came to Mrs. Hong’s village looking for her biological mother. Upon hearing the news, Mrs. Hong took leave from work and hurried to Thanh Oai (Hanoi), firmly believing the reunion was near. However, after matching information, the girl was not La Thi Hong Hanh. “At that time, it felt like the world had collapsed. I had high hopes but ended up with a bitter disappointment. Still, over the years, I have kept the faith that one day I would meet my daughter again,” she said.
Since receiving the DNA test results, Mrs. Hong’s life has returned to normal. At night, she has trouble sleeping from overwhelming joy and excitement, eagerly waiting for the day to reunite with her daughter.
For 31 years, she has never had a full night’s sleep. The memory of leaving her daughter at the orphanage remains an unending regret. Fortunately, her husband has always understood and is willing to accompany her on the journey to find their daughter.
“I’m not searching for money or material things. I just want to know how she is living and hope my daughter will forgive my past mistakes,” she said.
Currently, Mrs. Hong lives with her husband in a small house on Chinh Kinh street, Hanoi. They have one daughter who is now married.
Her husband suffered a stroke when he was young, so the economic burden has long rested on her shoulders. Life is not wealthy, but Mrs. Hong actively does charity work, hoping to atone in some way for past mistakes.
“After receiving the test results, I hope to hold my daughter in my arms even once, that would be enough. Whether she forgives me or not, I am ready to accept,” she said.
No Resentment Over the Past
Two days after receiving the DNA test results sent by Dan Tri to France, Léa was still overwhelmed with emotion. For more than 30 years, she never imagined a day she would see her biological mother’s image.
“I want to meet my mother but need a little more time to believe this is not a dream,” Léa shared.
According to Léa, her adoptive parents took her from Hanoi back to Paris in 1994. From childhood, she grew up in a loving family in France, receiving full care both materially and emotionally. They never hid the fact that Léa was adopted.
“When I was little, I wished one day to reunite with my family in Vietnam but was afraid my birth mother wouldn’t want to meet me. Since I turned 30, I decided not to search for any information about my origins to avoid getting hurt,” she said.

Léa said she hopes to soon return to Vietnam to visit and meet her biological mother. She had traveled to Vietnam with her adoptive parents when she was 10 years old. To this day, beautiful memories of Hanoi, Ha Long Bay, and the Mekong Delta remain vivid in her mind.
“I would like to thank Dan Tri newspaper and GENTIS testing center for helping my mother and me find each other after many years apart. This is a major turning point in my life,” Léa said.
“A drop of blood is worth more than a pond of water” — this saying has never grown old. In the age of technology, finding lost relatives might seem impossible, but with science and humanity, nothing is impossible.
GENTIS is proud to accompany people on this journey — the journey of bringing people back to their families, reuniting children with their mothers, and bringing smiles back to faces that once bore the pain of separation.
Because above all, every DNA test is not just a result — it is an opportunity for love to be restored.
[content_more] => [meta_title] => Hanoi Mother Overwhelmed with Emotion After Finding Her Daughter in France Thanks to Dan Tri Newspap [meta_description] => Thanks to the active involvement of Dan Tri newspaper, Mrs. La Thi Hong has found her daughter La Thi Hong Hanh (known by her French name, Léa) — who was adopted to France 31 years ago. [meta_keyword] => GENTIS [thumbnail_alt] => [post_id] => 1371 [category_id] => 14 ) [6] => stdClass Object ( [id] => 1370 [id_crawler] => [category_product] => NULL [thumbnail] => rabbit_media-2484.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 1 [displayed_time] => 2025-10-22 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2025-10-22 09:50:11 [updated_time] => 2025-10-23 09:37:43 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => GENTIS-parners-with-HSMFM-2025-joining-hands-to-improve-the-quality-of-maternal-and-fetal-healthcare-in-Vietnam [title] => GENTIS partners with HSMFM 2025: Joining hands to improve the quality of maternal and fetal healthcare in Vietnam [description] => The Ho Chi Minh City Maternal and Fetal Medicine Conference 2025 (HSMFM 2025) successfully concluded after two vibrant days from October 18 to 19, 2025, held at the Grand Saigon Hotel and Sheraton Saigon. With nearly 700 delegates and over 30 domestic and international speakers and chairpersons participating, the event once again affirmed its leading position in obstetrics and gynecology, fetal medicine, and genetics in Vietnam. Under the shared theme, "For the Health of Vietnamese Mothers and Fetuses," the conference was not only a platform for sharing the latest knowledge but also a bridge connecting research, application, and clinical practice. [content] =>
As a co-sponsor of this conference, GENTIS’s participation further demonstrates its strong commitment to promoting the application of genetic medicine in reproductive healthcare. Beyond providing advanced technological solutions, GENTIS contributed to the professional program with up-to-date content aimed at practical value for doctors and specialists.
One of the key highlights introduced by GENTIS at the conference was two modern genetic testing solutions widely applied in Vietnam, recently certified by the College of American Pathologists (CAP)—one of the top international standards for medical laboratories. Among them, the NIPT test (Non-Invasive Prenatal Testing) is increasingly becoming the standard in modern pregnancy management. With the ability to detect genetic abnormalities as early as the 9th week of pregnancy using only maternal blood samples, NIPT minimizes risks associated with invasive procedures like amniocentesis, while providing accurate information for doctors and expectant mothers to make informed medical decisions. Discussions at the conference clearly emphasized the importance of broad NIPT implementation, especially given the still-high rates of late detection of congenital abnormalities in many localities.

Additionally, GENTIS highlighted the role of PGT (Preimplantation Genetic Testing) in the field of assisted reproduction. Embryo screening before transfer—not only improving IVF success rates but also reducing the risk of passing genetic disorders to the next generation. With the rising rate of infertility and increasing demand for healthy childbirth, applying PGT has become an essential part of IVF protocols at many leading fertility centers. GENTIS currently offers PGT-A, PGT-M, and PGT-SR tests, expanding screening capabilities from chromosomal abnormalities to complex single-gene disorders.

Notably, at this conference, GENTIS proudly sponsored a scientific report titled “Gene Therapy in Fetuses: From Potential to Clinical Practice,” presented by Dr. Nguyen Van Thong—Head of Medical Genetics Department, Hung Vuong Hospital. The report attracted significant attention from the professional community as it discussed the emerging and promising field of gene therapy in fetal medicine. Developing gene therapies administered before birth, if systematically advanced, could fundamentally change the approach to treating congenital genetic diseases in Vietnam in the near future. This aligns with GENTIS’s long-term vision—not only providing genetic testing services but also accompanying the medical community in research, application, and technology transfer of advanced medical innovations.
HSMFM 2025 also served as a forum for experts to deeply discuss the standardization of fetal screening, diagnosis, and intervention processes, sharing experiences in managing high-risk pregnancies, and enhancing genetic counseling capacity. Case discussion sessions provided fresh insights, highlighting the urgent need for continuous knowledge updates and applying scientific technology to improve treatment quality.
By partnering with HSMFM 2025, GENTIS not only demonstrated its role as a reputable provider of genetic medicine services but also as a crucial link in Vietnam’s healthcare innovation ecosystem. This event marked another important milestone in GENTIS’s ongoing journey to contribute to building a preventive, precise, and personalized healthcare system, aiming to improve quality of life from the earliest stage—right from the womb.
[content_more] => [meta_title] => GENTIS partners with HSMFM 2025: Joining hands to improve the quality of maternal and fetal healthca [meta_description] => The Ho Chi Minh City Maternal and Fetal Medicine Conference 2025 (HSMFM 2025) successfully concluded after two vibrant days from October 18 to 19, 2025, held at the Grand Saigon Hotel and Sheraton Saigon. [meta_keyword] => GENTIS,HSMFM 2025 [thumbnail_alt] => [post_id] => 1370 [category_id] => 14 ) [7] => stdClass Object ( [id] => 1367 [id_crawler] => [category_product] => NULL [thumbnail] => 560425930_1216854540479735_2361199081791521294_n.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2025-10-15 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2025-10-15 10:01:29 [updated_time] => 2025-10-28 10:17:03 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => GENTIS-parners-with-andrology-and-fertility-hospital-of-hanoi-to-organize-october-prenatal-class [title] => GENTIS partners with Andrology and fertility hospital of Hanoi to organize october prenatal class [description] => Carrying the mission to accompany families on their journey to parenthood, GENTIS is proud to collaborate with Andrology and fertility hospital of Hanoi to organize the AF HANOI Prenatal Class with the theme “Dear Mom-to-Be, Don’t Miss Out.” [content] =>We understand that motherhood is a sacred journey, and to confidently step into this role, expectant mothers need not only knowledge but also support and proper guidance from experts and the community. This is not just a sharing session but an experience—an opportunity for both parents to mentally prepare and better understand the journey ahead as they await the arrival of their beloved baby.
Why should expectant mothers not miss the Prenatal Class?
Before their babies arrive, expectant mothers often have many concerns and worries—from bodily changes, nutrition, daily habits, to delivery methods, newborn care, and postpartum recovery. Without the right knowledge or guidance, mothers can easily become stressed, confused, or overwhelmed when “the moment” comes.
At the AF HANOI Prenatal Class, you will have the opportunity to hear directly from Dr. Luu Ba Hung and Dr. Hoang Duc Trung—two highly experienced obstetricians who have accompanied many mothers through pregnancy. Their shared knowledge is not only theoretical but also practical, with real-life stories from operating rooms and experiences of other mothers.
Moreover, expectant mothers will receive detailed guidance on nutrition, appropriate exercise, pregnancy monitoring, common complications, and early management. Mothers will also learn how to mentally prepare for labor—how to manage anxiety without being overwhelmed; how to reduce pain, choose the suitable delivery method, and prepare for a smooth birth.
The class doesn’t stop at “giving birth”—it also guides mothers on caring for their newborns from day one: breastfeeding, umbilical cord care, managing jaundice, skin care, sleep, fever prevention, and initial emergency handling. Additionally, mothers will be guided on postpartum body recovery, nutrition, gentle exercises, and maintaining mental health.
In a warm and friendly atmosphere, expectant mothers can ask any questions about pregnancy and childbirth—from “Why is the baby moving less?” to “Is a cesarean section dangerous?”—and receive thorough answers from the doctors.
Furthermore, GENTIS understands that the participation of mothers is precious. Therefore, many special gifts will be given to participants as tokens of gratitude and encouragement to help mothers feel valued and comprehensively cared for.

Details and Registration
Register now:
Online link: https://forms.gle/XZ9fwnwrxgo5x3kJA
Or scan the QR code on the promotional image for quick registration.
Note:
What will expectant mothers gain by joining the AF HANOI Prenatal Class?
Motherhood begins with small steps of preparation, knowledge, guidance, and support. Don’t miss out—register today to secure your spot at the AF HANOI Prenatal Class.
“Dear Mom-to-Be, Don’t Miss Out” is the sincere invitation from GENTIS and Hanoi Nam Học & Infertility Hospital to you, the mothers about to embark on this wonderful journey.
You are not just coming to a class but to receive companionship, sharing, guidance, and loving gifts. Take a few hours for yourself to gain confidence, knowledge, and a strong spirit to welcome your beloved baby.
We look forward to seeing you at the 5th Floor Hall – Andrology and fertility hospital of Hanoi on Saturday, October 25, 2025, from 9:30 AM to 11:00 AM.
Wishing all expectant mothers good health, peace of mind, and abundant love!
[content_more] => [meta_title] => GENTIS partners with Andrology and fertility hospital of Hanoi to organize october prenatal class [meta_description] => Carrying the mission to accompany families on their journey to parenthood, GENTIS is proud to collaborate with Andrology and fertility hospital of Hanoi to organize the AF HANOI Prenatal Class with the theme “Dear Mom-to-Be, Don’t Miss Out.” [meta_keyword] => GENTIS,expectant mom [thumbnail_alt] => [post_id] => 1367 [category_id] => 14 ) )